Key statistics
On Thursday, Arcus Biosciences Inc (RCUS:NYQ) closed at 8.47, 30.31% above the 52 week low of 6.50 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.60 |
---|---|
High | 8.75 |
Low | 8.33 |
Bid | 8.35 |
Offer | 8.85 |
Previous close | 8.59 |
Average volume | 1.15m |
---|---|
Shares outstanding | 105.89m |
Free float | 54.36m |
P/E (TTM) | -- |
Market cap | 896.85m USD |
EPS (TTM) | -4.19 USD |
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
More ▼
- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Announces New Employment Inducement Grants
- Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update
- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting
- Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update
- Arcus Biosciences Announces New Employment Inducement Grants
More ▼